Fig 1.
Geospatial distribution of the health facilities selected for conducting the sersurvey.
Orange triangle symbol indicate PMC public health facility; round green symbols indicate private health facilities of general practitioners.
Table 1.
Number and proportion of participants tested positive by indirect IgG ELISA in Pune, India, 2017.
Fig 2.
Percentage of participants tested positive by indirect ELISA in different municipal wards in Pune city.
Error bars show 95% confidence intervals.
Fig 3.
Percentage of participants tested positive by Indirect IgG ELISA in (A) age group ≤ 18 years, (B) adults in all study sites in Pune city. Error bars show 95% confidence intervals.
Fig 4.
Percentage of participants tested positive by IgG Capture ELISA according to age groups in all study sites in Pune city.
Error bars show 95% confidence intervals.
Table 2.
Distribution pattern of dengue serotype-specific neutralizing antibodies by PRNT.
Table 3.
Age group-wise dengue serotype specific neutralizing antibodies by PRNT in a subset of participants having antibody titers ≥10 (1/dil) against dengue viruses.
Fig 5.
PRNT90 antibody titers (log10) in different dengue serotypes (Red line indicates mean titers with standard deviation).
Fig 6.
Age group specific PRNT90 titers against the four DENV serotypes.
The error bars are 95% CI.
Fig 7.
Observed prevalence by age (with 95% CIs) and model-predicted values.
Data was aggregated into 3-year groups. Blue line: Model 1 (constant force of infection); Red line: Model 2 (different forces of infection above and below 18 years).
Table 4.
Estimates of the force of infection (λ, summed across all serotypes) obtained from models fit to dengue age-specific sero-prevalence data.